Well treatment fluids comprising cross-linkable polysaccharides

Patent metadata

Field	Value
Publication number	US-10150910-B2
Application number	US-201415325064-A
Country	US
Kind code	B2
Filing date	Jul 31, 2014
Priority date	Jul 31, 2014
Publication date	Dec 11, 2018
Grant date	Dec 11, 2018

Abstract

A method of treating a subterranean formation includes providing a treatment fluid comprising a crosslinkable polymer prepared by a redox reaction with vinyl phosphonic acid monomers or polymers and a polysaccharide, and at least one of a hydrolysable in-situ acid generator and a chelating agent, providing a carrier fluid comprising a brine, providing a metal crosslinker, placing all into a formation, allowing the polymer of to crosslink, and allowing the crosslinked polymer to become uncrosslinked. A wellbore fluid includes a crosslinkable polymer prepared by a redox reaction with vinyl phosphonic acid monomers or polymers and hydroxyethyl cellulose; at least one of a hydrolysable in-situ acid generator, a chelating agent, and mixtures thereof; a carrier fluid comprising a brine; and a metal crosslinker.

First claim

What is claimed is:

1. A method of treating a wellbore in a subterranean formation comprising:
placing a lost circulation treatment fluid into a lost circulation zone in the subterranean formation, the lost circulation treatment fluid comprising:
a carrier fluid comprising a brine;
a crosslinkable polymer prepared by a redox reaction with vinyl phosphonic acid monomers or polymers and a polysaccharide;
a hydrolysable in-situ acid generator;
a chelating agent; and
a metal crosslinker;

allowing at least a portion of the crosslinkable polymer to crosslink to form a crosslinked polymer;
allowing the hydrolysable in-situ acid generator to generate an acid and lower a pH of the lost circulation treatment fluid; and
allowing at least a portion of the crosslinked polymer to become un-crosslinked in response to the pH of the lost circulation treatment fluid.

2. The method of claim 1 , wherein the polysaccharide is selected from the group consisting of guar, hydroxypropyl guar, hydroxyethyl cellulose, hydroxypropyl cellulose, and mixtures thereof.

3. The method of claim 1 , wherein the crosslinkable polymer is a graft copolymer of hydroxyethylcellulose.

4. The method of claim 1 , wherein the hydrolysable in-situ acid generator comprises at least one hydrolysable strong acid ester that upon hydrolyzing yields an acid with a pKa of at most about zero.

5. The method of claim 4 , wherein the hydrolysable strong acid ester comprises at least one member selected from the group consisting of trimethyl orthoacetate, triethyl orthoacetate, tripropyl orthoacetate, triisopropyl orthoacetate, and poly(orthoacetates); orthoformates, such as trimethyl orthoformate, triethyl orthoformate, tripropyl orthoformate, triisopropyl orthoformate, and poly(orthoformates); and orthopropionates, such as trimethyl orthopropionate, triethyl orthopropionate, tripropyl orthopropionate, triisopropyl orthopropionate, and poly(orthopropionates), methyl tosylate and homologous series; methyl methane sulfonate and homologous series; methyl trichloroacetate and homologous series; methyl trifluroacetate and homologous series; dimethyl methylphosphonate and homologous series; and any combination thereof.

6. The method of claim 1 , wherein the chelating agent un-crosslinks the crosslinked polymer.

7. The method of claim 1 , wherein the chelating agent comprises at least one of the following: hydrolysable in-situ chelating agent generating compounds, ethylenediamine tetracetic acid (EDTA), nitrilotriacetic acid (NTA), N-(2-hydroxyethyl)ethyienediaminetriacetic acid (HEDTA), glutamic acid diacetic acid (GLDA), methylglycine diacetic acid (MGDA), iminodisuccinic acid (IDS), propylenediaminetetraacetic acid (PDTA), diethylenetriaminepentaacetic acid (DTPA), hydroxyethyliminodiacetic acid (HEIDA), cyclohexylenediaminetetraacetic acid (CDTA), diphenylaminesulfonic acid (DPAS), ethylenediaminedi(o-hydroxyphenylacetic) acid (EDDHA), glucoheptonic acid, gluconic acid, citric acid, β-alanine diacetic acid (β-ADA), ethylenediaminedisuccinic acid, S,S -ethylenediaminedisuccinic acid (EDDS), hydroxyiminodisuccinic acid (HIDS), polyamino disuccinic acids, N-bis[2-(1,2-dicarboxyethoxy)ethyl]glycine (BCA6), N-bis[2-(1,2-dicarboxyethoxy)ethyl]aspartic acid (BCA5), N-bis[2(1,2-dicarboxyethoxy)ethyl]methylglycine (MCBA5), N-tris[(1,2-dicarboxyethoxy)ethyl]amine (TCA6), N-bis[2-(carboxymethoxy)ethyl]glycine (BCA3), N-bis[2-(methylcarboxymethoxy)ethyl]glycine (MCBA3), N-methyliminodiacetic acid (MIDA), iminodiacetic acid (IDA), N-(2-acetamido)iminodiacetic acid (ADA), hydroxymethyl-iminodiacetic acid, 2-(2-carboxyethylamino) succinic acid (CEAA), 2-(2-carboxymethylamino) succinic acid (CMAA), diethylenetriamine-N,N″-disuccinic acid, triethylenetetramine-N,N′″-disuccinic acid, 1,6-hexamethylenediamine-N,N′-disuccinic acid, tetraethylenepentamine-N,N″″-disuccinic acid, 2-hydroxypropylene-1,3-diamine-N,N′-disuccinic acid, 1,2-propylenediamine-N,N′-disuccinic acid, 1,3-propylenediamine-N,N′-disuccinic acid, cis-cyclohexanediamine-N,N′-disuccinic acid, trans-cyclohexanediamine-N,N′-disuccinic acid, ethylenebis(oxyethylenenitrilo)-N,N′-disuccinic acid, glucoheptanoic acid, cysteic acid-N,N-diacetic acid, cysteic acid-N-monoacetic acid, alanine-N-monoacetic acid, N-(3-hydroxysuccinyl) aspartic acid, N-[2-(3-hydroxysucciny)]-L-serine, aspartic acid-N,N-diacetic acid, aspartic acid-N-monoacetic acid, any salt thereof, any derivative thereof, and any combination thereof.

8. The method of claim 1 , wherein an initial pH of the lost circulation treatment fluid is less than about 1.

9. The method of claim 1 , wherein upon being hydrolyzed, the hydrolysable in-situ acid generator decreases a pH of the lost circulation treatment fluid containing the crosslinked polymer to less than about 5.

10. The method of claim 1 , wherein the hydrolysable in-situ acid generator decreases a pH of the lost circulation treatment fluid comprising the crosslinked polymer such that the crosslinked polymer becomes at least partially un-crosslinked.

11. The method of claim 1 , wherein at least one of the hydrolysable in-situ acid generator or the chelating agent are encapsulated in a degradable material.

12. The method of claim 11 , wherein the degradable material is a hydrolysable material that delays generation of an acid by the hydrolysable in-situ acid generator or exposure of the chelating agent to a fluid present in the subterranean formation.

13. The method of claim 1 , wherein the hydrolysable in-situ acid generator is an orthoester with a general formula RC(OR′)(OR″)(OR′″), wherein R is a hydrogen, an alkyl group, or an aryl group, wherein R′, R″, and R′″ are each an alkyl group or an aryl group but not hydrogen, and R′, R″, and R′″ may or may not be the same group.

14. The method of claim 1 , wherein the metal crosslinker raises a pH of the lost circulation treatment fluid to at least about 8.

15. The method of claim 1 , wherein upon being hydrolyzed, the hydrolysable in-situ acid generator decreases a pH of the lost circulation treatment fluid comprising the crosslinked polymer to less than about 1, thereby hydrolyzing a backbone of the crosslinked polymer.

16. The method of claim 1 , wherein the brine is selected from the group consisting of NaCl, KCI, CaC 2 , NaBr, NH 4 Cl, sea water, CaCl 2 /CaBr 2 , and combinations thereof.

17. The method of claim 1 , further comprising mixing the lost circulation treatment fluid in a mixing tank fluidly coupled to a tubular.

18. The method of claim 17 , further comprising transporting the lost circulation treatment fluid to a wellhead by a pump fluidly coupled to said tubular.

19. A method comprising:
placing a lost circulation treatment fluid into a subterranean formation, the lost circulation treatment fluid comprising:
a first fluid comprising a crosslinkable polymer prepared by a redox reaction with vinyl phosphonic acid monomers or polymers and a polysaccharide, a hydrolysable in-situ acid generator, and a chelating agent;
a carrier fluid comprising a brine; and
a metal crosslinker,
wherein the lost circulation treatment fluid has an initial pH less than about 1;

allowing the pH of the lost circulation treatment fluid to rise to at least about 8;
allowing at least a portion of the crosslinkable polymer to crosslink to form a crosslinked polymer; and
allowing the hydrolysable in-situ acid generator to generate an acid and decrease the pH of the lost circulation treatment fluid to less than about 1; and
allowing at least a portion of the crosslinked polymer to become un-crosslin

Assignees

• Halliburton Energy Services Inc

Inventors

• Ogle James William
• Beuterbaugh Aaron M
• Singh Dipti

Classifications

• C09K8/10

  Cellulose or derivatives thereof · CPC title

• C09K8/514

  of natural origin, e.g. polysaccharides, cellulose (C09K8/512 takes precedence) · CPC title

• C09K8/035

  Organic additives · CPC title

• C09K8/685

  containing cross-linking agents · CPC title

• C09K8/5756

  containing cross-linking agents · CPC title